Intervention not reported
Mortality (all‐cause) ‐ formoterol versus placebo ( · patients with chronic asthma
The intervention showed no clear difference in mortality (all‐cause) ‐ formoterol versus placebo ( (moderate certainty).
1 finding from 1 review
- Regular treatment with formoterol for chronic asthma: serious adverse events 2012 · Cochrane Headline outcomes onlyOR 1.52 [0.24, 9.71]14 studies · 5463 participantsModerate